Barclays Reiterates “€76.00” Price Target for Fresenius Medical Care AG & Co. KGaA (FME)

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been assigned a €76.00 ($88.37) target price by Barclays in a research note issued on Wednesday. The brokerage presently has a “neutral” rating on the stock. Barclays’ target price would suggest a potential upside of 5.61% from the stock’s current price.

Several other research analysts have also issued reports on FME. Deutsche Bank set a €105.00 ($122.09) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Monday, July 16th. Oddo Bhf set a €96.00 ($111.63) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Wednesday, August 1st. JPMorgan Chase & Co. set a €96.10 ($111.74) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Wednesday, August 1st. Commerzbank set a €82.00 ($95.35) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Tuesday, July 31st. Finally, Cfra set a €90.00 ($104.65) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Thursday, August 2nd. Eight equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of €90.14 ($104.82).

Shares of ETR:FME opened at €71.96 ($83.67) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €75.53 ($87.83) and a 12-month high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Featured Story: Bull Market

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply